ArticleJournal of the Korean Society of Coloproctology2010

Oncologic outcome after cessation or dose reduction of capecitabine in patients with colon cancer.

Jung-A Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.